Artelo Biosciences Shares Drop After Announcement of $6.53M At-The-Market Offering
Artelo Biosciences Inc reported an at-the-market stock offering program of up to $6.53 million and named H.C. Wainwright & Co., LLC as exclusive sales agent, prompting a 20.5% fall in premarket trading. The prospectus supplement outlines the sales agreement, commission terms, prior sales activity and indemnification provisions for the sales agent.